Ajanta Pharma launches Montelukast Sodium Oral Granules in US market

17 Nov 2015 Evaluate

Ajanta Pharma’s subsidiary - Ajanta Pharma USA Inc., has launched Montelukast Sodium Oral Granules (4mg), a bioequivalent generic version of SINGULAIR Granules, in the US market. The company offers Montelukast Granules in cartons containing 30 individual sachets.

The approval and launch of the Montelukast Granules is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market. The United States Food & Drug Administration (USFDA) till date has granted five ANDA final approvals and two ANDA tentative approvals. An additional 19 ANDAs are pending approval from the USFDA.

Ajanta Pharma is a fully-integrated pharmaceutical company employing over 6,000 employees, engaged in developing, manufacturing and marketing of quality finished dosages across 35 countries.


Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×